| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Malady Kyle | EVP and Group CEO-VZ Business | VERIZON COMMUNICATIONS INC., 1095 AVENUE OF THE AMERICAS, NEW YORK | Evgeniya Berezkina, Attorney-in-fact for Kyle Malady | 2025-05-08 | 0001760581 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VZ | Common Stock | Sale | -$397K | -9K | -47.35% | $44.10 | 10K | May 7, 2025 | Direct | F1 |
| holding | VZ | Common Stock | 18.7K | May 7, 2025 | By 401(k) |
| Id | Content |
|---|---|
| F1 | The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices per share ranging from $44.095 to $44.112. The reporting person will provide to Verizon Communications Inc., any security holder of Verizon Communications Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |